FedCircuitBlog

Here is an update on recent en banc activity at the Federal Circuit. Last week the court heard oral argument in the en banc veterans case. As for petitions in patent cases, highlights include a new petition raising a question related to claim construction; new responses to petitions raising questions related to inter partes review and Rule 36 summary affirmances; a new invitation to respond to a petition raising questions related to deference to the Patent Trial and Appeal Board; a new amicus brief in a case raising questions related to inter partes review; and the denial of two petitions raising questions related to patent eligibility and transfer of venue. Here are the details.

Here is an update on recent en banc activity at the Federal Circuit in patent cases. Highlights include a new petition raising a question related to sovereign immunity and inter partes review; new invitations to respond to petitions raising questions related to inter partes review as well as the use of Rule 36 judgments in cases appealed from the U.S. Patent and Trademark Office; and the denial of a petition raising questions related to eligible subject matter. Here are the details.

• Fed. Circ. Again Says No State Sovereign Immunity In IPRs – In Board of Regents of the University of Texas System v. Baylor College of Medicine, the Federal Circuit held that plaintiffs can request inter partes reviews of state universities’ patents and sovereign immunity does not apply.
• Federal Circuit Tries to Wrap Its Arms Around Functional Biotech Patent Claims – The Federal Circuit heard oral arguments last Wednesday and focused on the application of the enablement requirement to Amgen’s patent covering therapeutic antibodies.
• Del. Chief Urges Creativity When Litigating Patent Eligibility – Chief Judge Leonard Stark addressed the resolution of patent eligibility issues within litigation during a panel discussion on Friday.

Here’s the latest.